Deutsche Bank Company Research broadens coverage of Healthcare
Mark Schoenebaum joins from Bear Stearns to cover Biotechnology
Deutsche Bank Securities Inc. today announced that Mark Schoenebaum has joined as a Managing Director and senior research analyst in Equity Company Research within the Global Markets division. Schoenebaum is based in New York and reports to Steve Pollard, Managing Director and Americas Head of Research.
Schoenebaum joins Deutsche Bank from Bear Stearns, where he was a Senior Managing Director covering Biotechnology in equity research. He has spent the past eight years as an equity research analyst, the last three of which he was ranked #1 in the Institutional Investor All-America Research poll for Biotechnology. Before joining Bear Stearns, Schoenebaum was co-director of Healthcare equity research at Alexandra Investment Management and spent two years as an analyst at Piper Jaffray. Schoenebaum earned a B.A. from Indiana University and an M.D. from Johns Hopkins University School of Medicine.
In addition, Robyn Karnauskas has joined as a Vice President and research analyst in Equity Company Research. Karnauskas was previously an Associate Director at Bear Stearns covering Biotechnology. She is based in New York and reports to Schoenebaum. Karnauskas earned a B.S. in Biology from the Massachusetts Institute of Technology and a Ph.D. in Cancer Biology from the University of Chicago.
“We are thrilled to add Mark and Robyn to our Healthcare team to cover Biotechnology,” said Pollard. “We are confident that their scientific knowledge and financial services experience will enhance the suite of objective, thematic and actionable ideas we regularly provide to our clients.”
For further information, please call:
About Deutsche Bank
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise. A leader in Germany and Europe, the bank is continuously growing in North America, Asia and key emerging markets. With 78,275 employees in 76 countries, Deutsche Bank competes to be the leading global provider of financial solutions for demanding clients creating exceptional value for its shareholders and people.
Deutsche Bank Securities Inc., member NYSE, NASD and SIPC, is the investment banking and securities arm of Deutsche Bank AG in the United States.